IVCY group (n=54) | conventional therapy group (n=36) | P value | |
---|---|---|---|
MPA,n (%) | 36 (67%) | 25 (69%) | 0.95 |
EGPA,n (%) | 6 (11%) | 3 (8%) | 0.56 |
GPA,n (%) | 8 (15%) | 2 (6%) | 0.36 |
PN,n (%) | 4 (7%) | 6 (17%) | 0.19 |
age (y) | 66.4±15.5 | 72.3±15.9 | 0.09 |
Male,n (%) | 19 (35%) | 13 (36%) | 0.93 |
FFS (d=0) | 0.6±0.7 | 0.7±0.8 | 0.40 |
BVAS (d=0) | 10.9±5.5 | 10.5±6.4 | 0.71 |
PSL (mg, d=0) | 50±11 | 38±13 | 0.39 |
PSL pulse,n (%) | 18 (33%) | 22 (61%) | 0.01 |
AZA,n (%) | 13 (24%) | 14 (39%) | 0.10 |
MTX,n (%) | 2 (4%) | 4 (11%) | 0.17 |
Abbreviation: MPA (microscopic polyangiitis), EGPA (eosinophilic granulomatosis with polyangiitis), GPA (granulomatosis with polyangiitis), PN (polyarteritis nodosa), BVAS (Birmingham Vasculitis Activity Score), AZA (azathioprine), MTX (methotrexate), d = 0 means day 0; the start of the treatment.